HIV & AIDS

Are there gender differences in anti-HIV drug efficacy?

Women comprise nearly half of the HIV-infected population worldwide, but these 15.5 million women tend to be under-represented in clinical trials of anti-HIV drug therapies. The U.S. Food and Drug Administration (FDA) has ...

HIV & AIDS

Potential drug molecule shows enhanced anti-HIV activity

Researchers from Munich and Naples have shown that minimal modification of a synthetic peptide with anti-HIV activity results in a new compound with more than two orders of magnitude higher binding affinity to the chemokine ...

HIV & AIDS

Pioneering research shows drug can purge dormant HIV

Researchers from the University of North Carolina at Chapel Hill have published pioneering research showing that a drug used to treat certain types of lymphoma was able to dislodge hidden virus in patients receiving treatment ...

HIV & AIDS

Gates urges more tools, vaccine to end AIDS

AIDS cannot be halted through treatment alone, and more prevention tools, in particular a vaccine, are needed to move seriously toward ending it, philanthropist Bill Gates said Monday.

page 8 from 17